HOME - ACR MEETING ABSTRACTSMEETINGS ARCHIVEKEYWORD INDEXADVANCED SEARCHYOUR FAVORITESACR CONVERGENCE 2020 DMARD Changes for Patients with Rheumatoid Arthritis in the US During the First Three Months of the COVID-19 Pandemic. Abstract Number: L06. Mavrilimumab (anti GM-CSF Receptor α Monoclonal Antibody) Reduces Time to Flare and Increases Sustained Remission in a Phase 2 Trial of Patients with Giant Cell Arteritis. Abstract Number: L07. ISOLATED ANTI-RO52 ANTIBODY Isolated anti-Ro52 antibody – significance and clinical association Background/Purpose: Antibodies against Ro-52 (TRIM21) have been described in patients with a broad spectrum of autoimmune diseases. Anti-Ro52 antibodies are the most common immunological markers detected in the idiopathic inflammatory myopathies. The significance and clinical association of isolated anti-Ro52 anti-body is HYDROXYCHLOROQUINE: A POTENTIAL TREATMENT FOR OSTEOPOROSIS Background/Purpose: We recently showed that patients with primary Sjögren Syndrome (pSS) have significantly higher bone mineral density (BMD) in the lumbar spine and femoral neck compared with healthy controls. The majority of those patients (69%) were using hydroxychloroquine (HCQ), which may have favourable effects on BMD. The aims of this study are to evaluate the TOFACITINIB IN EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSISTOFACITINIB CREAMTOFACITINIB DRUGTOFACITINIB INHALATIONTOFACITINIB MECHANISM OF ACTIONTOFACITINIB UPTODATETOFACITINIB VITILIGO Background/Purpose: Tofacitinib (TOFA) is a potent pan inhibitor of the Janus Kinase (JAK) family of kinases with a high degree of selectivity against JAK1 and JAK3 more than TYK2 or JAK2. This Phase I/II trial assessed the safety of TOFA 5 mg twice a day versus placebo (PLA) in diffuse cutaneous systemic sclerosis (dcSSc; clinicaltrials.gov NCT03274076). IMPORTANCE OF MIXED SPECKLED/ HOMOGENEOUS DFS70 ANASEE MORE ON

ACRABSTRACTS.ORG

CELL-BOUND COMPLEMENT ACTIVATION PRODUCTS (CB-CAP Background/Purpose: The onset of SLE, a prototypical autoimmune disease characterized by immune dysregulation and consequential inflammatory tissue injury, may be insidious with non-specific symptoms. The current standard for diagnosing SLE is based on the ACR classification criteria. A diagnosis of definite SLE is made when a patient has met 4 of the 11 criteria, which PREVALENCE OF CHRONIC KIDNEY DISEASE AND UNCONTROLLED Background/Purpose: Gout is the most common form of inflammatory arthritis, mainly caused by elevated serum uric acid (sUA) levels. The American College of Rheumatology guidelines recommend lowering sUA

levels to

YOUR FAVORITES

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your

favorites »

� COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY